INDP (Indaptus Therapeutics Inc) Net Profit

INDP (Indaptus Therapeutics, Inc.) - company brandmark

How can safe treatments for cancer and infections be created? This chart of current profits for Indaptus Therapeutics (INDP) on GURU.Markets reflects a trend where -0.02 describes the current status of the metric. The solution will be the expansion of the Decoy oncology platform to capture the immunopharmaceuticals market, supported by the seamless operation of research centers and partner manufacturing facilities.

INDP (Indaptus Therapeutics) Net Profit history from 07/04/2022 to 10/29/2026

Analytical breakdowns and data insights for company Indaptus Therapeutics, Inc. (INDP)

- price and consensus price forecast:
Stock Quotes Indaptus Corp|INDP - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Indaptus Corp|INDP - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share Indaptus Therapeutics|INDP - Book Capitalization|Market Capitalization to Book Value indaptusrx.com|INDP - Aggregate Company Assets
- debt and solvency information:
Total Debt to Equity Ratio Indaptus Therapeutics|INDP - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Indaptus Therapeutics Inc|INDP - Company Total Debt|Debts to Book Capitalization Indaptus Corp|INDP - Company Long-Term Debt|Company Short-Term Indebtedness Indaptus Therapeutics|Immediate Liquidity indaptusrx.com
- net income and valuation multiples indicators:
INDP - Net Profit
Summary company analysis:Indaptus Therapeutics
Core merchandise of Indaptus

The net operating profit dynamics of Indaptus Therapeutics (INDP) reflect the cumulative effect of cash flows, allowing investors to assess the speed at which fundamental business successes are capitalized in real-time. For Indaptus Therapeutics (INDP), this indicator serves as a gauge of market confidence in the development of universal immunotherapy, where any sharp spike on the chart signals a positive assessment of the potential of bacterial drugs in the fight against oncology and hepatitis.

Main competitors

Net Income argenx BVBA|BNTX (BioNTech SE) - Net Profit|Net Profit Abivax Pharma|Net Income ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Final Profit|Net Profit IMVT (Immunovant Corp)|Net Financial Result Kiniksa Corp (KNSA)|GRFS - Company Net Income|adaptivebiotech.com (ADPT) - Net Income|Celldex Therapeutics, Inc. (CLDX) - Company Net Income|Net Income Aurinia Pharmaceuticals Inc|Net Income BCRX|Net Profit Vera Corp|Company Net Income Dianthus Therapeutics (DNTH)|pharvaris.com - Company Profit|Net Profit ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Company Net Income|Intrexon - Net Profit|Net Financial Result Pharming Corp PHAR|Nektar Therapeutics (NKTR) - Company Net Income|Company Profit UPB|ZBIO (Zenas Biopharma) - Net Profit|Company Profit IMNM (Immunome Inc)|Net Profit GOSS|Net Profit KalVista Corp (KALV)|Company Net Income Septerna Inc SEPN|PVLA (pieris.com) - Profit After Tax|SVRA: Net Income|Rigel Pharma - Profit After Payment of Taxes|ANAB (AnaptysBio Corp) - Net Income|Astria Corp (ATXS) - Net Profit|Company Net Income enGene Holdings Inc.|rapt.com (RAPT) - Net Financial Result|Net Income JBIO (Aerovate Therapeutics Inc)|ACRS (Aclaris Therapeutics Inc.) - Final Profit|Kyverna - Net Income|Profit After Payment of Taxes TLSA (Tiziana Life Sciences, Ltd.)|Cabaletta Bio, Inc. - Net Profit|Final Profit VTYX (ventyxbio.com)|THTX: Net Profit|Company Net Income Avalo Therapeutics, Inc. (AVTX)|Company Net Income Eledon|AGEN: Final Profit|Net Profit CLYM|Net Profit zurabio.com (ZURA)|Company Net Income aTyr Pharma ATYR|ADAG (Adagene Inc) - Profit After Tax|Ikena Oncology, Inc. - Net Profit|Company Net Income Shattuck Labs, Inc.|EQ (equilliumbio.com) - Net Income|Connect Biopharma Holdings Limited (CNTB) - Net Profit|Net Income IMUX|ATRA (Atara Biotherapeutics Inc) - Profit After Payment of Taxes|Net Profit IFRX|Net Financial Result X4 Pharmaceuticals, Inc|Net Profit ACET (Adicet Bio, Inc.)|CELU - Net Income|INMB - Company Net Income|Net Financial Result Barinthus Biotherapeutics PLC BRNS|KZR: Net Profit|SABS - Net Financial Result|Company Net Income Akari Therapeutics|Company Profit ENLV (Enlivex Therapeutics, Ltd.)|Net Profit QTTB|GeoVax Labs - Company Profit|Company Net Income Edesa EDSA|IBIO (iBio Corporation) - Profit After Tax|CARM - Company Net Income|Profit After Tax XTLB|BOLT: Net Profit|HCW Biologics - Final Profit|APVO (Aptevo Therapeutics, Inc.) - Net Profit|Net Profit aimimmuno.com|Company Net Income Aditxt (ADTX)|GRI (gribio.com) - Final Profit|Company Net Income XORTX Therapeutics XRTX|HIND - Net Income|Revelation Bio - Net Profit|SCNI - Net Profit|CALI (calcimedica.com) - Net Income|Affimed N.V. - Final Profit|ALLK (Allakos Inc) - Net Profit|HOOKIPA (HOOK) - Net Financial Result|Company Net Income IGM Biosciences, Inc. (IGMS)|Net Income iTeos Pharma ITOS|Company Net Income Ocean Biomedical, Inc. OCEA|TCBP - Net Income|THRD: Net Income